The Use of Bellafill for Atrophic Acne Scar Correction in the Full Facial Area
Sponsor: Suneva Medical, Inc.
Listed as NCT02642627, this NA trial focuses on Atrophic Acne Scarring and remains completed. Sponsored by Suneva Medical, Inc., it has been updated 9 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 4 earlier versions
-
May 2020 — Jan 2021 [monthly]
Completed NA
-
Jun 2018 — May 2020 [monthly]
Completed NA
-
Jun 2017 — Jun 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jan 2017 — Jun 2017 [monthly]
Active Not Recruiting NA
First recorded
Nov 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Suneva Medical, Inc.
- ethica Clinical Research Inc.
For direct contact, visit the study record on ClinicalTrials.gov .